Mentalisation based versus psychodynamic group therapy in a day hospital treatment

Mentalisation based versus psychodynamic group therapy in a day hospital treatment - MBGT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00003396

Enrollment

150

Registered

2012-01-26

Start date

2011-09-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnosis of ICD-10 chapter V (F) with exception of F0, F2 and acute abuse of substance F10-F19 F30-F39 F40-F48 F50-F59 F60-F69 F80-F89 F90-F98

Interventions

Group 1: Mentalization based group therapy in a day clinic setting (Within a day clinic setting patients receive mentalization based group psychotherapy four times per week with a duration of 90 minut

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of ICD-10 chapter V (F)

Exclusion criteria

Exclusion criteria: diagnosis F0, F2 of ICD-10 chapter V (F) and significant difficulties in german language and cognitive impairment

Design outcomes

Primary

Measure	Time frame
Primary efficacy endpoint is the reduction of global severity impairment evaluated by the patients (GSI/ SCL-90-R) twelve month after treatment.	—

Secondary

Measure	Time frame
Key secondary endpoints in the perspective of patients are different aspects of mentalization abilities (LEAS, MASC, AQ-k), interpersonal problems (IIP-D) and goals of therapy (GAS). Secondary endpoints in the perspectives of the therapists and the experts are the global (GAF) and social (SOFAS) functioning, the global severity impairment (BSS), the aims of therapy (exclusively therapists) and mental disorders of axis one and two of DSM-IV (SCID I and I; exclusively experts). The main points of assessments are before, after therapy and twelve month after therapy. At this points the SCL-90-R, LEAS, MASC, subtests 1 and 4 of the LPS, AQ-k, IIP-D, GAF, SOFAS and BSS are used. The aims of therapy are only assessed before and after therapy. SCID I and II are used before therapy and twelve months after therapy. To assess the process the patients complete the SCL-90-R weekly and evaluate the group climate (GCQ) after each group. The therapists complete the GAF, SOFAS and BSS after four weeks of therapy. The adherence of therapy is rated by trained experts. For this randomly chosen audiotapes of group sessions are rated with a self developed questionnaire. Furthermore a semistructured in-depth interview with the patients is used to assess the curative factors.	—

Measure

Time frame

Key secondary endpoints in the perspective of patients are different aspects of mentalization abilities (LEAS, MASC, AQ-k), interpersonal problems (IIP-D) and goals of therapy (GAS). Secondary endpoints in the perspectives of the therapists and the experts are the global (GAF) and social (SOFAS) functioning, the global severity impairment (BSS), the aims of therapy (exclusively therapists) and mental disorders of axis one and two of DSM-IV (SCID I and I; exclusively experts). The main points of assessments are before, after therapy and twelve month after therapy. At this points the SCL-90-R, LEAS, MASC, subtests 1 and 4 of the LPS, AQ-k, IIP-D, GAF, SOFAS and BSS are used. The aims of therapy are only assessed before and after therapy. SCID I and II are used before therapy and twelve months after therapy. To assess the process the patients complete the SCL-90-R weekly and evaluate the group climate (GCQ) after each group. The therapists complete the GAF, SOFAS and BSS after four weeks of therapy. The adherence of therapy is rated by trained experts. For this randomly chosen audiotapes of group sessions are rated with a self developed questionnaire. Furthermore a semistructured in-depth interview with the patients is used to assess the curative factors.

—

Countries

Germany

Contacts

Public ContactUlrich Schultz-Venrath

Klinik für Psychiatrie, Psychotherapie und Psychosomatik des EVK Bergisch Gladbach - Kooperationsklinik der Universität Witten/Herdecke

schultzvenrath@freenet.de02202-1223100

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026